faricimab

Spain

Drugs containing this active substance

  • VABYSMO 120 MG/ML SOLUTION FOR INJECTION

    It is used to treat certain eye disorders in adults that affect central vision, such as neovascular age-related macular degeneration, diabetic macular edema, and macular swelling caused by retinal vein occlusion.

    Form: solution for injection

    Active substance Dosage
    faricimab 28,8 mg

    ATC: S01L S01LA S01LA09

    Manufacturer: Roche Registration Gmbh

  • VABYSMO 120 MG/ML SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

    It is used to treat eye disorders in adults that affect central vision, such as neovascular age-related macular degeneration (nAMD), vision impairment due to diabetic macular edema (DME), and vision impairment due to retinal vein occlusion (retinal branch vein occlusion or central retinal vein occlusion).

    Form: solution for injection in a pre-filled syringe

    Active substance Dosage
    faricimab 21 mg

    ATC: S01L S01LA S01LA09

    Manufacturer: Roche Registration Gmbh